Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections
2007

Impact of Vancomycin Susceptibility on MRSA Bloodstream Infections

Sample size: 20 publication Evidence: moderate

Author Information

Author(s): Neoh Hui-min, Hori Satoshi, Komatsu Mitsutaka, Oguri Toyoko, Takeuchi Fumihiko, Cui Longzhu, Hiramatsu Keiichi

Primary Institution: Juntendo University

Hypothesis

Is there a correlation between the clinical outcome of patients with MRSA bacteraemia and the vancomycin susceptibility of the corresponding strains?

Conclusion

The study suggests that poor vancomycin treatment responses may indicate the presence of MRSA strains with reduced susceptibility to vancomycin.

Supporting Evidence

  • 20 out of 209 MRSA bacteraemia patients were treated with vancomycin for at least 5 days.
  • A significant difference in vancomycin susceptibility was found between patients with good and poor treatment responses.
  • Correlation tests showed a significant positive linear correlation between AUC and therapeutic response parameters.

Takeaway

Doctors should pay attention to patients who don't respond well to vancomycin, as it might mean the bacteria are harder to treat.

Methodology

A retrospective study linking vancomycin susceptibility profiles of MRSA isolates with hospitalization data.

Potential Biases

Strict inclusion and exclusion criteria may have introduced selection bias.

Limitations

The study had a small sample size and was retrospective, which may limit the generalizability of the findings.

Participant Demographics

Mean age of participants was 54.5 years, with 12 men and 8 women.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/1476-0711-6-13

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication